AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

FISHER & PAYKEL HEALTHCARE C

30.760

-0.600-1.91%

Volume:141.20K

Turnover:4.55M

Market Cap:18.03B

PE:108.57

High:31.200

Open:30.890

Low:30.680

Close:31.360

Loading ...

Overview Company News Filings

Top Premarket Decliners

MT Newswires Live

5 'particularly interesting' ASX All Ords stocks to buy amid the Trump tariff mayhem

Stock Track | Fisher & Paykel Healthcare Soars 5.13% as It's Well-Positioned to Withstand U.S. Tariffs

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock's On A Decline: Are Poor Fundamentals The Cause?

Simply Wall St.

Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare

BUZZ-Fisher & Paykel's ASX-listed shares rise; Morgan Stanley initiates coverage, hikes PT for NZ shares

Tariffs on US Imports to Rise to Highest Level in Almost a Hundred Years; Jarden Research Says

MT Newswires Live

Should I buy Fisher & Paykel or ResMed shares?

Australian Shares Fall as Tariffs Cause Global Selloff; Fisher & Paykel Expects Higher Costs in Fiscal Year 2026

MT Newswires Live

Fisher & Paykel shrugs off red Thursday as investors satisfied tariff risks under control

The Market Herald

ASX Preview: Australian Shares to Open Higher as Global Markets Digest Sweeping Tariffs From US

MT Newswires Live

Fisher & Paykel Expects Higher Costs in Fiscal 2026 Due to New US Tariffs; Shares Fall 5%

MT Newswires Live

Here are the top 10 ASX 200 shares today

NZX Midday Sector Update: Health Technology Soars, Consumer Durables Tank

MT Newswires Live

Why buying Australian shares in 2025 could be the right investment

New Zealand Shares Fall as Investors Track Wall Street Losses on Continued Trade Jitters

MT Newswires Live

Fisher & Paykel Healthcare Launches F&P Nova Nasal Mask for Obstructive Sleep Apnea in Australia, New Zealand

MT Newswires Live

New Zealand Shares Flat, Asian Equities Track Wall Street Gains on Tariff Reprieve, China Stimulus Hopes

MT Newswires Live

Fisher & Paykel Healthcare to Start Construction of Fifth Building in New Zealand for NZ$250 Million

MT Newswires Live

19 ASX stocks that should be on your radar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FPH.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FPH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPH.AU\",,,,,undefined,":{"symbol":"FPH.AU","market":"AU","secType":"STK","nameCN":"FISHER & PAYKEL HEALTHCARE C","latestPrice":30.76,"timestamp":1745297087494,"preClose":31.36,"halted":0,"volume":141200,"delay":0,"nameEN":"FISHER & PAYKEL HEALTHCARE C","floatShares":583930680,"shares":586256654,"eps":0.2833264750738061,"marketStatus":"Trading","change":-0.6,"latestTime":"04-22 14:44:53 AEST","open":30.89,"high":31.2,"low":30.68,"amount":4551847,"amplitude":0.016582,"askPrice":30.76,"askSize":6,"bidPrice":30.74,"bidSize":90,"shortable":3,"etf":0,"ttmEps":0.2833264750738061,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745301600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":31.36,"dividendRate":0.012783,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":0.399845,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPH.AU\",,,,,undefined,":{"symbol":"FPH.AU","floatShares":583930680,"roa":"10.85%","roe":"9.70%","lyrEps":0.213273,"volumeRatio":0.399845,"shares":586256654,"dividePrice":0.393138,"high":31.2,"amplitude":0.016582,"preClose":31.36,"low":30.68,"week52Low":23.6,"pbRate":"9.98","psRate":"10.19","week52High":35.745,"institutionHeld":0,"latestPrice":30.76,"committee":0.875,"eps":0.2833264750738061,"divideRate":0.012783,"volume":141200,"delay":0,"ttmEps":0.2833264750738061,"open":30.89,"prevYearClose":34.95,"prevWeekClose":31.36,"prevMonthClose":30.25,"prevQuarterClose":30.25,"fiveDayClose":31.17,"twentyDayClose":29.72,"sixtyDayClose":35.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FPH.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527290662","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2527290662","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527290662?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:36","pubTimestamp":1744803386,"startTime":"0","endTime":"0","summary":"Viavi Solutions (VIAV) shares slumped 38% pre-bell Wednesday following a muted session.Five Point Holdings (FPH) shares fell 28% after Tuesday's 3.6% gain.DiamondRock Hospitality (DRH) stock was down 23% following a 1.3% loss in the previous session.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0240878834.USD","VIAV","FPH","BK7007","LU0240877869.USD","LU0205193047.USD","FPH.AU","LU0205194284.USD","DRH","BK4020","BK4218","BK4193","BK4181","BK7501"],"gpt_icon":0},{"id":"2527511133","title":"5 'particularly interesting' ASX All Ords stocks to buy amid the Trump tariff mayhem","url":"https://stock-news.laohu8.com/highlight/detail?id=2527511133","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527511133?lang=en_us&edition=fundamental","pubTime":"2025-04-14 13:12","pubTimestamp":1744607549,"startTime":"0","endTime":"0","summary":"The All Ordinaries Index  is up a welcome 1.38% on Monday, but most ASX All Ords stocks remain well down from the market highs on 14 February. Indeed, the All Ords is still down 9.78% since notching its record closing high on the day. The headwinds that have dragged on global and Aussie stock markets alike since then can largely be pinned on the unpredictable and oft-changing trade policies under United States President Donald Trump. Trump's sweeping global tariffs, in particular, have unsettled investors. This, in turn, sent many ASX All Ords stocks tumbling despite no likely fundamental changes to their long-term prospects. \"We, like almost every other investor on the planet, underestimated Trump's resolve to reshape global trade and just how far he appears willing to go to do this,\" said Jun Bei Liu, founder and lead portfolio manager at Ten Cap . Liu pointed to Trump's 2 April 'Liberation Day' tariff announcement as having \"drastically changed the course of the macroeconomic and in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/14/5-particularly-interesting-asx-all-ords-stocks-to-buy-amid-the-trump-tariff-mayhem/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","BK7016","FPH.AU","XAO.AU","BK7002","BK7501","REA.AU","BK7503","BK7007","COH.AU","PME.AU","360.AU"],"gpt_icon":0},{"id":"1155896764","title":"Stock Track | Fisher & Paykel Healthcare Soars 5.13% as It's Well-Positioned to Withstand U.S. Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=1155896764","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155896764?lang=en_us&edition=fundamental","pubTime":"2025-04-10 08:10","pubTimestamp":1744243826,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Ltd  saw its stock soar 5.13% in Thursday's trading session, outperforming the broader market. The surge comes amid positive analyst commentary on the company's positioning in the face of potential U.S. tariffs.According to a recent broker note from Macquarie Group, Fisher & Paykel Healthcare is relatively well-positioned compared to some of its Australian healthcare peers. The company's products, manufactured in Mexico, are compliant under the USMCA  and c","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Fisher & Paykel Healthcare Soars 5.13% as It's Well-Positioned to Withstand U.S. Tariffs","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["FPH.AU"],"gpt_icon":0},{"id":"2526325104","title":"Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock's On A Decline: Are Poor Fundamentals The Cause?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526325104","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526325104?lang=en_us&edition=fundamental","pubTime":"2025-04-10 07:26","pubTimestamp":1744241207,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at Fisher & Paykel Healthcare's  recent performance, when its stock has declined 13% over the past three months. To decide if this trend could continue, we decided to look at its weak fundamentals as they shape the long-term market trends. Particularly, we will be paying attention to Fisher & Paykel Healthcare's  ROE today.Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.Return on Equity = Net Profit  ÷ Shareholders' Equity. So, based on the above formula, the ROE for Fisher & Paykel Healthcare is:. Fisher & Paykel Healthcare's Earnings Growth And 9.2% ROE. So, as a next step, we compared Fisher & Paykel Healthcare's performance against the industry and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fisher-paykel-healthcare-corporation-limited-232647122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4193","BK7007","FPH.AU","FPH.NZ","FPH","BK4137","HCSG","BK8004","BK7501"],"gpt_icon":0},{"id":"2526990342","title":"Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2526990342","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526990342?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:12","pubTimestamp":1744233120,"startTime":"0","endTime":"0","summary":"] A key challenge for both RMD and FPH will be negotiations with US payors to increase pricing or widening co-payments. We note upside risk for both names if respiratory devices/apparatus are exempt from tariffs under the Nairobi Protocol implemented through the Harmonised Tariff Schedule.  That said, ResMed isn't completely immune. With part of its manufacturing based in Australia and Singapore, both now facing 10% tariffs, and rising input costs from tariffed raw materials, its earnings forecasts have been trimmed by 2% for FY 2026 and FY 2027. What about CSL and Cochlear?Biotech giant CSL Ltd  escaped the current round of tariffs, thanks to exemptions for pharmaceutical products. However, Macquarie flagged it as a name to watch. It said:  CSL is left unscathed by reciprocal tariffs as pharmaceuticals are exempted. However, potential sector tariffs remain a key risk for CSL in the near term.  As for Cochlear Ltd , it also sidestepped the tariff net, as hearing devices continue to enj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/10/trump-2-0-macquaries-take-on-the-winners-and-losers-in-australian-healthcare/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7046","RMD.AU","COH.AU","BK7508","ANN.AU","CSL.AU","FPH.AU","XAO.AU","BK7067","XKO.AU","BK7007","BK7511","MQG.AU","XJO.AU","BK7126","BK7501"],"gpt_icon":0},{"id":"2525836447","title":"BUZZ-Fisher & Paykel's ASX-listed shares rise; Morgan Stanley initiates coverage, hikes PT for NZ shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2525836447","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525836447?lang=en_us&edition=fundamental","pubTime":"2025-04-08 13:39","pubTimestamp":1744090743,"startTime":"0","endTime":"0","summary":"BUZZ-Fisher & Paykel's ASX-listed shares rise; Morgan Stanley initiates coverage, hikes PT for NZ shares** Australia-listed shares of Fisher & Paykel Healthcare FPH.AX rise as much as 1.8% to A$31.39 ** Morgan Stanley initiates coverage on medical equipment maker, rated 'equal-weight' on stock, price target set at A$34** Brokerage sees solid earnings growth with favourable long-term outlook, supported by increased clinical adoption ** Brokerage hikes its PT for co's shares in New Zealand FPH.NZ to NZ$36.70 from NZ$36.30, seeing less material U.S. tariff impacts on co** Fisher & Paykel's NZ shares up 0.3% at NZ$33.55","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nL6N3QM0BO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FPH","FPH.AU","BK7501","BK4193","BK7007"],"gpt_icon":0},{"id":"2524273512","title":"Tariffs on US Imports to Rise to Highest Level in Almost a Hundred Years; Jarden Research Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2524273512","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524273512?lang=en_us&edition=fundamental","pubTime":"2025-04-04 15:14","pubTimestamp":1743750852,"startTime":"0","endTime":"0","summary":"Tariffs on US imports are set to rise to their highest levels since the 1930s, with the weighted average expected to reach 29.4%, according to a Thursday note by Jarden Research.Jarden noted that the ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7505","BK7503","BK7007","LU0368265418.SGD","LU0742534661.SGD","TWE.AU","LU0251142724.SGD","XAO.AU","BK7016","BK7097","LU0314104364.USD","LU0345770308.USD","BK7002","LU0345780950.USD","LU0170899867.USD","BK4144","BK7501","LU0345770993.USD","CAR.AU","WTC.AU","LU0122376428.USD","IE00B29SXK94.USD","BK7142","FPH.AU","IE00B29SXL02.USD","LU2449327464.USD","LNG","LU0345781412.USD","WDS.AU","LU0048573561.USD","LU0630314457.HKD","LU0251131958.USD","XKO.AU","LU0788109394.HKD","XJO.AU"],"gpt_icon":0},{"id":"2524278832","title":"Should I buy Fisher & Paykel or ResMed shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524278832","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524278832?lang=en_us&edition=fundamental","pubTime":"2025-04-04 11:48","pubTimestamp":1743738489,"startTime":"0","endTime":"0","summary":"Both companies are global leaders with strong track records, but when it comes to deciding which to buy today, the case for ResMed shares looks particularly compelling.Fisher & Paykel is a New Zealand-based medical device company that designs, manufactures and markets equipment used in acute and chronic respiratory care, surgical applications, and sleep apnoea treatment.The company has a presence in more than 120 countries and has built a strong reputation over decades. However, despite the quality of the business, analysts are taking a more measured view for now.Morgan Stanley currently has an equal-weight  rating on the stock with a $36.30 price target, compared to its recent share price of $31.40. That represents some upside, but the broker isn't quite ready to call it a buy.Goldman Sachs recently reaffirmed its conviction buy rating on ResMed shares with a $49.00 price target, well above the current share price of $33.82.For investors looking for growth, value, and global exposure ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/04/should-i-buy-fisher-paykel-or-resmed-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2237443465.HKD","LU1868837300.USD","IE00BFXG1179.USD","LU2750360641.GBP","BK4552","LU0314104364.USD","LU2133065610.SGD","RMD.AU","BK4127","LU0158827781.USD","LU0225283273.USD","LU0742534661.SGD","LU0096364046.USD","LU2471134796.USD","LU0158827948.USD","LU1720051017.SGD","RMD","IE0004086264.USD","LU1548497426.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU2008162690.USD","LU1074936037.SGD","BK8004","BK4588","LU2237443622.USD","FPH.NZ","LU0106831901.USD","LU2237438978.USD","LU0912757837.SGD","LU1868836591.USD","LU2111349929.HKD","BK4548","LU0048573561.USD","BK4533","LU1791807156.HKD","BK4516","LU0061475181.USD","IE00B19Z3B42.SGD","LU0320765646.SGD","LU2471134879.HKD","LU1732800096.USD","LU2237443978.SGD","BK4504","FPH.AU","LU1720051108.HKD","BK4534","IE0004091025.USD","IE00BSNM7G36.USD","BK7501"],"gpt_icon":0},{"id":"2524401615","title":"Australian Shares Fall as Tariffs Cause Global Selloff; Fisher & Paykel Expects Higher Costs in Fiscal Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2524401615","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524401615?lang=en_us&edition=fundamental","pubTime":"2025-04-03 14:02","pubTimestamp":1743660127,"startTime":"0","endTime":"0","summary":"Australian shares fell on Thursday's close, tracking Wall Street markets, after Trump implemented hefty tariffs on all imports to the US.The S&P/ASX 200 fell 0.9% or 74.8 points to close at 7,859.7.Th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK8004","ANN.AU","XAO.AU","XJO.AU","BK7135","ANZ.AU","BK7007","COH.AU","BK7119","BK7501","BK7511","BK7126","FPH.AU","XKO.AU","BRG.AU","FPH.NZ"],"gpt_icon":0},{"id":"2524213421","title":"Fisher & Paykel shrugs off red Thursday as investors satisfied tariff risks under control","url":"https://stock-news.laohu8.com/highlight/detail?id=2524213421","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524213421?lang=en_us&edition=fundamental","pubTime":"2025-04-03 08:41","pubTimestamp":1743640860,"startTime":"0","endTime":"0","summary":"It’s Trump Tariff Thursday and traders are scrambling to figure out who to sell and who to keep in their portfolios.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Perhaps surprisingly, FIsher & Paykel Healthcare  – a company that produces around 40% of its goods in Mexico – has survived. Or, at least, the share price hasn’t tanked.“The company does not anticipate a material impact from the US tariffs on its net profit after tax for the 2025 financial year, which ended 31 March 2025,” FPH wrote on Thursday.But FY26 is a different story. There, Fisher & Paykel expect company costs to increase as well as higher exposure to risk around forex volatility.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/fisher-paykel-shrugs-off-red-thursday-as-investors-satisfied-tariff-risks-under-control-2025-04-03/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["FPH.AU","BK7007","BK7501","FPH.NZ"],"gpt_icon":0},{"id":"2524350428","title":"ASX Preview: Australian Shares to Open Higher as Global Markets Digest Sweeping Tariffs From US","url":"https://stock-news.laohu8.com/highlight/detail?id=2524350428","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524350428?lang=en_us&edition=fundamental","pubTime":"2025-04-03 06:58","pubTimestamp":1743634690,"startTime":"0","endTime":"0","summary":"Australian shares are expected to open higher Thursday, but trading will likely be volatile as investors absorb the Trump administration's global tariffs.The international trade goods and job vacancy ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NWS.AU","BK7038","FPH.AU","BK7501","XKO.AU","XAO.AU","BK7007","XJO.AU"],"gpt_icon":0},{"id":"2524447861","title":"Fisher & Paykel Expects Higher Costs in Fiscal 2026 Due to New US Tariffs; Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524447861","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524447861?lang=en_us&edition=fundamental","pubTime":"2025-04-03 06:13","pubTimestamp":1743632022,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare  said the 10% US tariffs on products manufactured in New Zealand will not significantly impact its fiscal 2025 net profit but are expected to drive higher costs in fiscal 2026, according to a Thursday filing with the Australian and New Zealand bourses.About 55% of its production is based in New Zealand, with around 40% of its US volumes supplied from there, the filing added, the filing said.Shares of the company fell almost 5% in New Zealand in recent Thursday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","FPH.AU","BK7007","NZ50G.NZ","FPH.NZ","NZ20C.NZ","T10G.NZ"],"gpt_icon":0},{"id":"2522890943","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2522890943","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522890943?lang=en_us&edition=fundamental","pubTime":"2025-03-26 13:59","pubTimestamp":1742968750,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index (ASX: XJO) enjoyed a strong day this Wednesday, perhaps thanks to the latest inflation figures from the Australian Bureau of Statistics (ABS). After a rather timid start to the w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/26/here-are-the-top-10-asx-200-shares-today-26-march-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LTR.AU","BK7007","BK7511","BK7505","BGA.AU","SPR.AU","XJO.AU","BK7030","BK7162","BK7141","BK7135","BK7095","BK7084","RMS.AU","CDA.AU","BK7510","FPH.AU","BK7501","SCG.AU","ANZ.AU","BK7123","BK7504","BK7160","BK7104","BK7506","QAN.AU","BK7005","HLI.AU"],"gpt_icon":0},{"id":"2522797856","title":"NZX Midday Sector Update: Health Technology Soars, Consumer Durables Tank","url":"https://stock-news.laohu8.com/highlight/detail?id=2522797856","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522797856?lang=en_us&edition=fundamental","pubTime":"2025-03-26 09:00","pubTimestamp":1742950853,"startTime":"0","endTime":"0","summary":"Health technology stocks gained the most on the New Zealand exchange, rising past 3% by midday Wednesday.Fisher & Paykel Healthcare  shares rose 5% in recent trade.On the other hand, consumer durable shares dropped past 1%.KMD Brands   shares slid 3% in recent trade as it posted a wider fiscal first-half loss of NZ$0.03, compared with a loss of NZ$0.014 per diluted share a year earlier.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZX.NZ","NZ50G.NZ","BK7501","BK7128","KMD.AU","T10G.NZ","NZ20C.NZ","FPH.AU","BK8020","BK7007"],"gpt_icon":0},{"id":"2519850349","title":"Why buying Australian shares in 2025 could be the right investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2519850349","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519850349?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:30","pubTimestamp":1741887000,"startTime":"0","endTime":"0","summary":"The global share market has been rocked by a growing tariff trade war between the United States and other countries, including Canada, China, Mexico, and the EU. Australian shares have also suffered f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/14/why-buying-australian-shares-in-2025-could-be-the-right-investment/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BSL.AU","BK7511","BK7042","BK7153","BK7007","ROC.AU","BK7148","FPH.AU","BHP.AU","RIO.AU","XKO.AU","TLS.AU","BK7501","BK7105","BK7041","XAO.AU","BK7507","BK7083","SOL.AU","WES.AU","APA.AU","BK7129","XJO.AU","BK7024","BK7095"],"gpt_icon":1},{"id":"2518035247","title":"New Zealand Shares Fall as Investors Track Wall Street Losses on Continued Trade Jitters","url":"https://stock-news.laohu8.com/highlight/detail?id=2518035247","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518035247?lang=en_us&edition=fundamental","pubTime":"2025-03-12 12:41","pubTimestamp":1741754516,"startTime":"0","endTime":"0","summary":"New Zealand shares declined for a second straight session this week as investors tracked losses on Wall Street amid continued market jitters over the scale of the impact of US tariffs.The S&P/NZX 50 I","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ50G.NZ","BK7501","ISBC","BK7042","SPK.AU","T10G.NZ","NZ20C.NZ","FPH.AU","BK4211","BK7007"],"gpt_icon":0},{"id":"2518050287","title":"Fisher & Paykel Healthcare Launches F&P Nova Nasal Mask for Obstructive Sleep Apnea in Australia, New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2518050287","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518050287?lang=en_us&edition=fundamental","pubTime":"2025-03-12 06:50","pubTimestamp":1741733458,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare  launched the F&P Nova Nasal mask in Australia and New Zealand, according to a Wednesday filing with the bourses in both countries.The mask is designed to treat obstructive sleep apnea. Fisher & Paykel plans to launch the product in other countries once clearances are received, per the filing.The company's Kiwi shares were down almost 3% in recent Wednesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["T10G.NZ","BK4137","XKO.AU","FPH.NZ","NZ20C.NZ","XAO.AU","BK7007","BK7501","BK8004","FPH.AU","HCSG","XJO.AU","NZ50G.NZ"],"gpt_icon":0},{"id":"2517902315","title":"New Zealand Shares Flat, Asian Equities Track Wall Street Gains on Tariff Reprieve, China Stimulus Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2517902315","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517902315?lang=en_us&edition=fundamental","pubTime":"2025-03-06 12:50","pubTimestamp":1741236621,"startTime":"0","endTime":"0","summary":"New Zealand shares were flat Thursday, deviating from gains in Asia and the US following a tariff reprieve for automakers and hopes for stimulus from China in response to the trade war.The S&P/NZX 50 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ20C.NZ","NZ50G.NZ","BK7501","FPH.AU","T10G.NZ","BK7007"],"gpt_icon":0},{"id":"2517992047","title":"Fisher & Paykel Healthcare to Start Construction of Fifth Building in New Zealand for NZ$250 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517992047","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517992047?lang=en_us&edition=fundamental","pubTime":"2025-03-06 06:43","pubTimestamp":1741214621,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare  awarded a construction contract to Dominion Constructors for the fifth building on its East Tamaki campus in Auckland, according to a Thursday filing with the New Zealand and Australian bourses.The 28,000-square-meter building is estimated to cost NZ$250 million and will house facilities for research and development, manufacturing, and distribution. Construction will start within the month, with the facilities expected to be operational in 2027, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ20C.NZ","NZ50G.NZ","FPH.AU","T10G.NZ","BK4137","BK7007","HCSG","FPH.NZ","BK7501"],"gpt_icon":1},{"id":"2517951957","title":"19 ASX stocks that should be on your radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2517951957","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517951957?lang=en_us&edition=fundamental","pubTime":"2025-03-05 13:29","pubTimestamp":1741152599,"startTime":"0","endTime":"0","summary":"Please note this interview was filmed on 3 March 2025. Another reporting season is in the books, so it’s time again to sit down with the Yarra Capital Management Equities team to discuss the key takeaways and, more importantly, what lies ahead.I was joined by Marcus Ryan, Michael Steele, and Joel Fleming, who represent the entire market cap spectrum, from micro to large caps. Below is a summary of the key themes and stocks discussed but, if you want the full experience, make sure to watch the video.According to Ryan, one of the key highlights of the season was that many companies demonstrated strong cost control, leading to better-than-expected margins despite only 10% of ASX 200 companies beating sales expectations.This trend was evident across various sectors, including resources and building materials. Boral, now within Seven Group , exemplified this improvement.After strong performance over the past 12 months, banks declined around. earnings , with growing competition and margin pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/19-asx-stocks-that-should-be-on-your-radar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/19-asx-stocks-that-should-be-on-your-radar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BSL.AU","VSL.AU","BK7511","MGH.AU","BK7110","BK7143","SGH.AU","BK7007","TCL.AU","BK7148","BK7104","BK7031","EOL.AU","FPH.AU","BHP.AU","SFR.AU","BK7120","BK7012","NST.AU","BK7126","RIO.AU","RMD.AU","XKO.AU","BK7055","BK7501","ANN.AU","XAO.AU","BK7507","APE.AU","BK7506","SGM.AU","APA.AU","BK7129","RWC.AU","XJO.AU","BK7090","EVN.AU","BK7016","BK7095"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FPH.AU\",params:#limit:5,,,undefined,":[{"date":"2024-12-05","symbol":"FPH.AU","amount":0.256944,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-12-06","name":"FISHER & PAYKEL HEALTHCARE C","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-06","currency":"NZD","dateTimestamp":1733317200000,"payDate":"2024-12-18"},{"date":"2024-06-26","symbol":"FPH.AU","amount":0.326389,"announcedDate":null,"type":"dividend","market":"AU","newRecordDate":"2024-06-27","defaultRemindTime":1719360000000,"name":"FISHER & PAYKEL HEALTHCARE C","recordDate":"2024-07-10","payableDate":"2024-06-27","currency":"NZD","dateTimestamp":1719324000000,"payDate":"2024-07-10"},{"date":"2023-12-05","symbol":"FPH.AU","amount":0.0317647,"announcedDate":"2023-11-29","type":"dividend","market":"AU","newRecordDate":"2023-12-06","defaultRemindTime":1701730800000,"name":"Fisher & Paykel Healthcare Corp","recordDate":"2023-12-18","payableDate":"2023-12-06","currency":"NZD","dateTimestamp":1701694800000,"payDate":"2023-12-18"},{"date":"2023-06-26","symbol":"FPH.AU","amount":0.0405882,"announcedDate":"2023-05-26","type":"dividend","market":"AU","newRecordDate":"2023-06-27","defaultRemindTime":1687737600000,"name":"Fisher & Paykel Healthcare Corp","recordDate":"2023-07-07","payableDate":"2023-06-27","currency":"NZD","dateTimestamp":1687701600000,"payDate":"2023-07-07"},{"market":"AU","date":"2022-12-08","symbol":"FPH.AU","amount":0.0308823,"defaultRemindTime":1670454000000,"name":"Fisher & Paykel Healthcare Corp","recordDate":"2022-12-21","payableDate":"2022-12-09","currency":"NZD","type":"dividend","dateTimestamp":1670418000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FPH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-07-06","recordDate":"2020-07-07","paymentDate":"2020-07-17","value":0.0273594,"currency":"NZD"},{"executeDate":"2020-12-03","recordDate":"2020-12-04","paymentDate":"2020-12-16","value":0.16,"currency":"NZD"},{"executeDate":"2021-06-24","recordDate":"2021-06-25","paymentDate":"2021-07-07","value":0.0388235,"currency":"NZD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-15","value":0.03,"currency":"NZD"},{"executeDate":"2022-06-22","recordDate":"2022-06-23","paymentDate":"2022-07-06","value":0.0397058,"currency":"NZD"}]}}